🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21285Original Research

Differences in angiogenesis and osteogenic effects between autogenous bone and mixed bone in guided bone regeneration

YANG Ning¹,HAN Zekui¹,WANG Xinyu¹,HUANG Yiping¹,HAN Jiaqi¹,WANG Yu¹,DUAN Feng¹

Key Laboratory of Oral Biomedical Materials and Clinical Applications of Heilongjiang Province, Jiamusi University, Jiamusi 154002, Heilongjiang Province, China

Read Executive PreviewQuick FAQ
Differences in angiogenesis and osteogenic effects between autogenous bone and mixed bone in guided bone regeneration
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1898, Issue 26 • pp. 100-112Citation:YANG Ning et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Early angiogenesis and bone regeneration are more pronounced with autologous bone powder alone compared to a 1:1 mixture with artificial bone powder. • By 12 weeks postoperatively, the osteogenic and angiogenic outcomes of the mixed graft are comparable to those of autologous bone alone. • The autologous bone group showed a more significant increase in vascular cross-sections during the early phase (2-7 days). • Bone volume fraction was significantly higher in the autologous bone group at 8 weeks, but the difference disappeared by 12 weeks.
Sponsored Research Highlight

Abstract

BACKGROUND: Angiogenesis is a key factor in the success of guided bone regeneration, but the impact of different bone graft materials on angiogenesis and osteogenic effects remains unclear. OBJECTIVE: To compare the angiogenesis and osteogenic effects of autologous bone powder and the mixture of autologous bone powder and artificial bone powder during guided bone regeneration. METHODS: Preoperative scanning of the jawbone data of New Zealand white rabbits using cone beam CT was performed to extract a rabbit jawbone model, which was then 3D printed to create a bone cutting guide plate. Twenty-one New Zealand white rabbits were used to construct a rabbit mandibular bone defect model. Each rabbit had two bone defect areas on both sides, one side was the autologous bone powder + artificial bone powder group, implanted with a mixture of autologous bone powder and artificial bone powder at a volume ratio of 1:1; the other side was the autologous bone powder group, implanted with autologous bone powder only. Angiogenesis and osteogenesis in the bone defect area were detected at 2, 5, 7, 14 days and 4, 8, 12 weeks after modeling. RESULTS AND CONCLUSION: (1) At 12 weeks postoperatively, the tissue morphology and angiogenesis of the autologous bone powder group and the autologous bone powder + artificial bone powder group were similar; (2) The number of vascular cross-sections in the autologous bone powder group showed a more significant upward trend at 2-7 days, while the trends of the two groups were similar in other periods; (3) At 8 weeks postoperatively, the distribution range of new bone in the autologous bone powder + artificial bone powder group was not as large as that in the autologous bone powder group. At 12 weeks, the continuity and density of bone tissue in both groups were better, close to normal bone tissue morphology; (4) At 8 weeks, the bone volume fraction of the autologous bone powder group was significantly higher than that of the autologous bone powder + artificial bone powder group (P < 0.05). At 12 weeks, there was no significant difference in bone volume parameters between the two groups (P > 0.05); (5) The results indicate that early angiogenesis and bone regeneration were more obvious with autologous bone powder implantation, but by 12 weeks postoperatively, the effect of mixed implantation of autologous bone powder and artificial bone powder was similar to that of autologous bone powder alone in repairing rabbit mandibular defects, indicating that with the progress of bone remodeling, the comprehensive effects of the two materials tend to be consistent.

1. Introduction

Guided bone regeneration (GBR) is a minimally invasive and efficient bone repair method that has gradually become a key approach for treating bone defects [1]. This technique utilizes a barrier membrane to prevent rapidly migrating cells from entering the defect area, creating a favorable environment for osteogenic cells and promoting bone healing [2]. In the field of oral and maxillofacial surgery, GBR is widely applied for reconstructing alveolar bone defects due to its maturity and reliability [3-4]. Current research on GBR mainly focuses on guided bone tissue, while morphological studies on early neovascularization during GBR are relatively scarce, and the growth pattern of blood vessels after bone graft material implantation remains unclear.

Early angiogenesis in the bone defect area is crucial for the success of GBR [5]. When osteoblasts are more than 100-200 μm away from blood vessels, they die due to hypoxia and nutrient deficiency [6-7]. Therefore, sufficient vascular ingrowth can supply blood, providing essential oxygen, nutrients, growth factors, and hormones to osteoblasts, while effectively removing metabolic waste, ensuring a stable and healthy cellular environment [8-9]. Moreover, during later bone tissue repair and regeneration, blood vessels are closely connected with newly formed bone tissue, and the ingrowth of new blood vessels provides a suitable microenvironment for the migration, proliferation, and differentiation of osteoprogenitor cells, promoting bone matrix synthesis and mineralization [10-11].

Bone graft materials, along with blood clots, serve as scaffolds for new blood vessels and bone tissue to 'climb' in the GBR defect area, guiding new bone regeneration to a predetermined height [12]. Currently, commonly used bone graft materials include autogenous bone, allograft bone, xenograft bone, and alloplastic bone [13]. Although autogenous bone is considered the gold standard for bone defect repair due to its osteoconductivity, osteoinductivity, and osteogenicity, it has limitations such as limited availability, the need for a second surgical site causing patient morbidity, and high resorption rate after transplantation, which restrict its clinical application [14]. Therefore, autogenous bone is often combined with bone substitutes in clinical practice [15]. This study selected Hai'ao bone powder, which is widely used clinically in China, as the artificial bone powder. Hai'ao bone repair material is made from bovine decellularized bone matrix, with a three-dimensional porous structure highly similar to human cancellous bone, exhibiting excellent biocompatibility and osteoconductivity, and playing an important role in maintaining a stable osteogenic environment and promoting neovascularization [16]. However, further research on the relationship between new blood vessels and bone powder is insufficient, and the impact of different bone graft materials on angiogenesis and osteogenesis remains unclear.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
YANG Ning, HAN Zekui, WANG Xinyu, HUANG Yiping, HAN Jiaqi, WANG Yu, DUAN Feng (2026). Differences in angiogenesis and osteogenic effects between autogenous bone and mixed bone in guided bone regeneration. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21285
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the main objective of this study?

The main objective is to compare the angiogenesis and osteogenic effects of autologous bone powder alone versus a 1:1 mixture of autologous bone powder and artificial bone powder during guided bone regeneration in a rabbit mandibular defect model.

How was the animal model established?

Twenty-one New Zealand white rabbits were used. Preoperative cone beam CT scans were taken to create a 3D-printed cutting guide. Each rabbit had two bone defects created in the mandible, one side filled with autologous bone powder and the other with a 1:1 mixture of autologous and artificial bone powder.

What were the key findings regarding angiogenesis?

The autologous bone powder group showed a more significant increase in vascular cross-sections during the early phase (2-7 days), but by 12 weeks, the angiogenic outcomes were similar between the two groups.

What were the key findings regarding osteogenesis?

At 8 weeks, the autologous bone group had a significantly higher bone volume fraction than the mixed group. However, by 12 weeks, there was no significant difference, indicating that the mixed graft achieved comparable bone regeneration over time.

What is the clinical implication of this study?

The study suggests that while autologous bone alone may promote earlier angiogenesis and bone formation, a 1:1 mixture with artificial bone can achieve similar long-term outcomes, potentially reducing the need for large amounts of autologous bone and associated donor site morbidity.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF